Adaptive Biotechnologies Corporation(ADPT)

$14.81▲0.38 (2.63%)

Adaptive Biotechnologies Corporation(ADPT)

NASDAQ

$14.81▲0.38 (2.63%)

Overview Intelligence Chart Fundamentals Key Metrics Earnings Growth Analysts Financials Insiders Institutional

Analyst Sentiment

Analysts lean bullish — 65% recommend buying.

Consensus Rating

Buy

17 analysts·Moderate coverage

65%

Rating Distribution

Strong Buy

00%

Buy

1165%

Hold

424%

Sell

212%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 43% higher.

Bear Case

$21.00

+42%

Consensus

$21.25

+43%

Bull Case

$22.00

+49%

Price Range17 analysts

Low

Consensus

High

$21.00

$22.00

Current Target

Current Price

$14.81

Upside to Target

$6.44

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+22.72%

EPS—

FY2028

Rev+19.79%

EPS—

FY2029

Rev+21.59%

EPS—

Earnings Surprises

Recent Analyst Actions

Feb 6, 2026BTIG

Adaptive Biotechnologies price target raised to $22 from $21 at BTIG

Target:$22.00

+33.6%from $16.47

Feb 6, 2026Piper Sandler

Adaptive Biotechnologies price target raised to $21 from $20 at JPMorgan

Target:$21.00

+27.5%from $16.47

Jan 26, 2026Guggenheim

Adaptive Biotechnologies price target raised to $21 from $20 at Guggenheim

Target:$21.00

+11.1%from $18.91

Dec 1, 2025Morgan Stanley

Adaptive Biotechnologies assumed with an Equal Weight at Morgan Stanley

Target:$21.00

+11.5%from $18.84

Oct 15, 2025Piper Sandler

Adaptive Biotechnologies price target raised to $20 from $15 at Piper Sandler

Target:$20.00

+22.9%from $16.28

Sep 30, 2025Guggenheim

Guggenheim starts Adaptive with Buy on cancer test leadership

Target:$20.00

+48.6%from $13.46

Apr 4, 2024BTIG

Adeptus Biotechnologies Corp. (ADPT) PT Lowered to $5 at BTIG, 'assign a lower valuation to the businesses'

Target:$5.00

+86.6%from $2.68

Dec 21, 2022Piper Sandler

Adaptive Biotechnologies upgraded to Overweight from Neutral at Piper Sandler

Target:$14.00

+97.5%from $7.09

Aug 17, 2022Piper Sandler

Adaptive Biotechnologies price target raised to $12 from $7.50 at Piper Sandler

Target:$12.00

+3.9%from $11.55

Jun 13, 2022Piper Sandler

Adaptive Biotechnologies (ADPT) Stock Price: $7.50 Target From Piper Sandler

Target:$7.50

+7.6%from $6.97

May 6, 2022Morgan Stanley

Morgan Stanley Maintains Equal-Weight on Adaptive Biotechnologies, Lowers Price Target to $18

Target:$18.00

+120.9%from $8.15

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance